Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Moderate vs Severe Rheumatoid Arthritis
NCT00896168Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Jun 2007; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00896168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896168.